Biotech developing microbial immunotherapies for women's health.
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Funding round Freya Biosciences raised $10.4M from the Gates Foundation plus $1.4M from EIFO to advance its DYSCOVER microbial immunotherapy platform for women's health. | $11.8M |
| Dec 2023 | Series A Copenhagen biotech Freya Biosciences raised a 38M USD Series A led by Sofinnova Partners and OMX Ventures to advance reproductive immunotherapies. | $38M |